Meeder Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.8K Buy
633
+370
+141% +$35.4K ﹤0.01% 430
2025
Q4
$25.3K Sell
263
-3
-1% -$291 ﹤0.01% 495
2025
Q3
$25.3K Sell
266
-14,556
-98% -$1.34M ﹤0.01% 393
2025
Q2
$1.29M Buy
14,822
+39
+0.3% +$3.31K 0.08% 122
2025
Q1
$1.33M Sell
14,783
-104
-0.7% -$9.31K 0.09% 115
2024
Q4
$1.19M Sell
14,887
-153,074
-91% -$13.3M 0.08% 112
2024
Q3
$15.1M Buy
167,961
+167,610
+47,752% +$14.1M 1.01% 24
2024
Q2
$27.6K Sell
351
-3,341
-90% -$274K ﹤0.01% 448
2024
Q1
$322K Buy
3,692
+375
+11% +$32K 0.02% 253
2023
Q4
$273K Buy
3,317
+254
+8% +$19.4K 0.02% 235
2023
Q3
$240K Sell
3,063
-18
-0.6% -$1.51K 0.02% 246
2023
Q2
$271K Sell
3,081
-62
-2% -$5.34K 0.02% 240
2023
Q1
$253K Sell
3,143
-265
-8% -$21.6K 0.02% 260
2022
Q4
$265K Sell
3,408
-13,741
-80% -$1.11M 0.02% 331
2022
Q3
$1.39M Sell
17,149
-1,446
-8% -$130K 0.08% 191
2022
Q2
$1.67M Buy
18,595
+996
+6% +$101K 0.1% 175
2022
Q1
$1.95M Buy
+17,599
New +$1.86M 0.1% 159
2021
Q4
Sell
-112,106
Closed -$14.1M 1844
2021
Q3
$14.1M Sell
112,106
-2,914
-3% -$377K 0.74% 25
2021
Q2
$14.3M Sell
115,020
-126
-0.1% -$15.8K 0.67% 31
2021
Q1
$13.6M Buy
115,146
+106,075
+1,169% +$12.4M 0.7% 27
2020
Q4
$1.06M Sell
9,071
-106,431
-92% -$11.7M 0.24% 79
2020
Q3
$12M Sell
115,502
-5,135
-4% -$516K 0.78% 22
2020
Q2
$11.1M Sell
120,637
-1,936
-2% -$186K 0.72% 28
2020
Q1
$11.1M Sell
122,573
-264
-0.2% -$28.1K 0.86% 20
2019
Q4
$13.9M Sell
122,837
-215
-0.2% -$23.6K 0.85% 20
2019
Q3
$13.4M Sell
123,052
-235
-0.2% -$24.5K 0.89% 18
2019
Q2
$12M Buy
123,287
+2,345
+2% +$214K 0.84% 23
2019
Q1
$11M Buy
120,942
+2,037
+2% +$182K 0.87% 21
2018
Q4
$10.8M Sell
118,905
-3,728
-3% -$348K 0.96% 16
2018
Q3
$12.1M Buy
122,633
+51,472
+72% +$4.76M 0.91% 20
2018
Q2
$6.09M Buy
71,161
+27,857
+64% +$2.33M 0.52% 57
2018
Q1
$3.47M Buy
43,304
+23,752
+121% +$1.96M 0.32% 80
2017
Q4
$1.58M Sell
19,552
-15,001
-43% -$1.2M 0.13% 148
2017
Q3
$2.69M Buy
34,553
+33,664
+3,787% +$2.79M 0.29% 86
2017
Q2
$79K Sell
889
-3,579
-80% -$302K 0.01% 601
2017
Q1
$360K Sell
4,468
-64,538
-94% -$5.04M 0.03% 432
2016
Q4
$4.92M Buy
69,006
+1,414
+2% +$111K 0.47% 61
2016
Q3
$5.84M Buy
67,592
+25,162
+59% +$2.19M 0.5% 35
2016
Q2
$3.68M Buy
42,430
+4,744
+13% +$384K 0.34% 54
2016
Q1
$2.83M Buy
37,686
+34,393
+1,044% +$2.59M 0.27% 81
2015
Q4
$254K Buy
3,293
+1,507
+84% +$113K 0.02% 485
2015
Q3
$120K Buy
1,786
+1,686
+1,686% +$124K 0.01% 580
2015
Q2
$7K Hold
100
﹤0.01% 455
2015
Q1
$8K Hold
100
﹤0.01% 494
2014
Q4
$7K Buy
+100
New +$6.95K ﹤0.01% 433
2013
Q4
Sell
-176,948
Closed -$9.42M 368
2013
Q3
$9.42M Sell
176,948
-13,535
-7% -$728K 1.79% 9
2013
Q2
$9.8M Buy
+190,483
New +$9.42M 1.95% 3

Other funds holding MDT

Meeder Asset Management's MDT Position: Q1 2026 in Review

Meeder Asset Management increased its Medtronic (MDT) stake by 141% in Q1 2026, buying an estimated $35.4K and bringing the position to 633 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

Meeder Asset Management first reported a position in MDT in Q2 2013 and has held it in 47 quarters since. The position peaked at $15.1M in Q3 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Meeder Asset Management held 633 shares of Medtronic worth $54.8K as of Q1 2026.
  • Meeder Asset Management bought 370 Medtronic shares in Q1 2026, an estimated $35.4K.
  • Medtronic made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #430 holding.
  • Meeder Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 47 quarters since.
  • Meeder Asset Management's Medtronic position peaked at $15.1M in Q3 2024.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.